CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 2,421 enrolled
Drug / intervention
Capillary blood sample +1 moreprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01954264
NCT01954264N/ACompleted
CompareCT.gov

Epidemiology Study of Malariometric Determinants in Selected Post-Approval Programme Study Sites in Sub-Saharan Western Africa

GlaxoSmithKline·interventional·Posted Oct 1, 2013·Updated Jan 21, 2020

In Brief

A clinical study evaluating Capillary blood sample and Data collection for Malaria. Completed, enrolled 2,421 participants across 3 sites in 2 countries.

Detailed Summary

This study is designed to characterise P. falciparum transmission intensity in subjects aged ≥6 months and \<10 years by measurement of P. falciparum parasite prevalence, and to estimate the use of malaria control interventions at some centres selected for the EPI-MAL-002 and EPI-MAL-003 studies in sub-Saharan Western Africa.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMalaria
CountriesBurkina Faso, Senegal
Collaborators--

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedOct 1, 2013
Enrollment StartOct 19, 2013
Primary CompletionNov 22, 2013
Study CompletionNov 25, 2013
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 12.8 years ago

Interventions

Capillary blood sampleprocedure

Capillary blood sample (up to 200µL) for determination of PP (blood slides).

Data collectionother

Prospective data collection at the study visit by the internet based Electronic Case Report Form (eCRF)